- Presentations
- 3
- Markets
- 1
Brevibloc is a brand of Esmolol marketed by Baxter Healthcare, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Esmolol
- Brand owner
- Baxter Healthcare
- Registered in
- United States
- Strengths and forms
- 100 mg/10 mL injection, 2000 mg/100 mL injection, 2500 mg/250 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Brevibloc 100 mg/10 mL injectionIntravenous | Baxter Healthcare | US FDA | Available on request |
| Brevibloc 2000 mg/100 mL injectionIntravenous | Baxter Healthcare | US FDA | Available on request |
| Brevibloc 2500 mg/250 mL injectionIntravenous | Baxter Healthcare | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Brevibloc
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.